Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03865771
Other study ID # 6995
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 27, 2019
Est. completion date September 2024

Study information

Verified date June 2023
Source University Hospital, Strasbourg, France
Contact Anne DE SAINT MARTIN, MD
Phone + 33 3.88.12.83.98
Email anne.desaintmartin@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Age related focal epilepsies in children encompasses, according to the ILAE criteria, benign epilepsy with centro temporal spikes (BECTS), atypical benign partial epilepsy (ABPE) and epileptic encephalopathy with continuous spike and waves during sleep (ECSWS). These non structural epilepsies are associated with interictal sleep spike and waves activated by sleep. Moreover, high prevalence of learning disorders occur in children with age related epilepsies. A correlation is suspected between learning disorders and sleep activation of spike and waves. The investigators suppose that learning dysfunction is linked to loss of information during sleep of epileptic children, unlike for control patients. As sleep allows memory consolidation of words learned during wakefulness, an epileptic activity during sleep may disrupt this consolidation, leading to a loss of information. Hypothesis: the investigators hypothesize a disruption of memory consolidation after one night in children affected with ABPE and ECSWS (severe group) compared to memory consolidation in children affected with BECTS (benign group), and control group. Primary purpose: To demonstrate that the deficit of delayed recall in 15 word learning test after one night is higher for the "severe group", compared to the "benign group" and the control group. Secondary purposes: - to study the evolution over time of memory consolidation - to evaluate the correlation of the deficit of delayed recall with executive dysfunction, clinical factors of epilepsy, neurophysiological factors of epilepsy, and sleep architecture


Recruitment information / eligibility

Status Recruiting
Enrollment 95
Est. completion date September 2024
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 6 Years to 13 Years
Eligibility Inclusion Criteria: Principal: - normal psychomotor development - informed consent signed by both parents and subject if able - affiliated to social security regimen Specific Patients from "severe" and "benign" groups: - focal age related epilepsy: BECTS, ABPE, ECSWS (ILAE criteria) - children hospitalized for their follow-up - normal neuroimaging Control group -children hospitalized for a non neurologic disease Exclusion Criteria: Principal: Psychiatric trouble (DSM V) Sensorial trouble without correction Poor command of French language Minor under care Specific Patients from "severe" and "benign" groups: - degenerative disease - abnormal neuroimaging - mental deficiency Control group - neurologic trouble - abnormal sleep EEG - intellectual deficiency

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Neuropsychological testing
memory, executive testing, behaviour questionnaire, visual attention,
Neuropsychological procedure
Rey auditory verbal learning test, Delayed recall : 1h, 5h, 24h (after one night sleep)
Other:
Video EEG and polysomnography
Video EEG : 10 electrodes + 3 electrodes for PSG 2h wake EEG Whole night EEG

Locations

Country Name City State
France Hopital D'Enfants Pediatrie Medicale Ambulatoire Nancy
France Hopital de Hautepierre-Service de Pediatrie/Neurologie Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary memory lapse rate at 24 hours in the severe group, the benign group and the control group. ("memory lapse rate": rate of non recalled words number, during the delayed recall phase of the test, related to the maximal number of words recalled 24 hours
Secondary memory lapse rate for each group at 1 hour, 5 hours, 24 hours
Secondary Correlation of memory lapse rate with Executive functioning tests scores at 1 hour, 5 hours, 24 hours
Secondary Correlation of memory lapse rate with age of onset, epilepsy phase, treatment at 1 hour, 5 hours, 24 hours
Secondary Correlation of memory lapse rate with EEG severity scale, atypical criteria, EEG focus localization, sleep discharges frequency at 1 hour, 5 hours, 24 hours
Secondary Correlation of memory lapse rate with number and organization of sleep cycles at 1 hour, 5 hours, 24 hours